Author:
Abdel Fattah Shereen,Ibrahim Mohamed Emad El-Din,El-Din Shimaa Saad,Emam Hadeel Sayed,Algaleel Waleed Ahmed Abd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference66 articles.
1. Pathology of benign prostatic hyperplasia;Roehrborn;Int. J. Impot. Res.,2008
2. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019;Zhu;Mil. Med. Res.,2021
3. Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia;Pawlicki;Pol. Merkur. Lekarski,2004
4. Benign prostate hyperplasia: a review of the year’s progress from bench to clinic;Donnell;Curr. Opin. Urol.,2011
5. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium;Wang;Prostate,2004